journal article·2024-10-01Open access

Simultaneous Protein and RNA Analysis in Single Extracellular Vesicles, Including Viruses

Zach Troyer, Olesia Gololobova, Aakash Koppula, Zhaohao Liao, Felix Horns, Michael B. Elowitz, Juan Pablo Tosar, Mona Batish, Kenneth W. Witwer

ACS Nano· Volume 18· Issue 39

Abstract

The individual detection of human immunodeficiency virus (HIV) virions and resolution from extracellular vesicles (EVs) during analysis is a difficult challenge. Infectious enveloped virions and nonviral EVs are released simultaneously by HIV-infected host cells, in addition to hybrid viral EVs containing combinations of HIV and host components but lacking replicative ability. Complicating the issue, EVs and enveloped virions are both delimited by a lipid bilayer and share similar size and density. The feature that distinguishes infectious virions from host and hybrid EVs is the HIV genomic RNA (gRNA), which allows the virus to replicate. Single-particle analysis techniques, which provide snapshots of single biological nanoparticles, could resolve infectious virions from EVs. However, current single-particle analysis techniques focus mainly on protein detection, which fail to resolve hybrid EVs from infectious virions. A method to simultaneously detect viral protein and internal gRNA in the same particle would allow resolution of infectious HIV from EVs and noninfectious virions. Here, we introduce SPIRFISH, a high-throughput method for single-particle protein and RNA analysis, combining single particle interferometric reflectance imaging sensor with single-molecule fluorescence in situ hybridization. Using SPIRFISH, we detect HIV-1 envelope protein gp120 and genomic RNA within single infectious virions, allowing resolution against EV background and noninfectious virions. We further show that SPIRFISH can be used to detect specific RNAs within EVs. This may have major utility for EV therapeutics, which are increasingly focused on EV-mediated RNA delivery. SPIRFISH should enable single particle analysis of a broad class of RNA-containing nanoparticles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · RNA Interference and Gene Delivery · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

EV Core Facility “EXCEL”, Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

Department of Medical and Molecular Sciences, and Department of Biological Sciences, University of Delaware, Newark, Delaware 19716, United States

Howard Hughes Medical Institute and Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, United States

Functional Genomics Laboratory, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay

School of Science, Universidad de la República, Montevideo 11400, Uruguay

The Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

Funding

Division of Molecular and Cellular Biosciences · National Institute of Biomedical Imaging and Bioengineering · Ionis Pharmaceuticals · Paul G. Allen Family Foundation · National Institute of Mental Health · Burroughs Wellcome Fund · Comisi?n Sectorial de Investigaci?n Cient?fica · California Institute of Technology

References (67)

Show source-provided references
1. 10.1172/JCI8731610.1172/JCI87316 ↗
2. 10.3402/jev.v4.2706610.3402/jev.v4.27066 ↗
3. 10.3402/jev.v2i0.2067710.3402/jev.v2i0.20677 ↗
4. 10.1083/jcb.20121113810.1083/jcb.201211138 ↗
5. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
6. 10.1016/j.ymthe.2023.01.02110.1016/j.ymthe.2023.01.021 ↗
7. 10.3390/pharmaceutics1212117110.3390/pharmaceutics12121171 ↗
8. 10.1038/s12276-019-0223-510.1038/s12276-019-0223-5 ↗
9. 10.1038/s41596-021-00551-z10.1038/s41596-021-00551-z ↗
10. 10.1186/s12929-019-0502-410.1186/s12929-019-0502-4 ↗
11. 10.1016/S0065-3233(03)01010-610.1016/S0065-3233(03)01010-6 ↗
12. 10.3389/fcimb.2020.59317010.3389/fcimb.2020.593170 ↗
13. 10.1073/pnas.160514611310.1073/pnas.1605146113 ↗
14. 10.3390/v1402038310.3390/v14020383 ↗
15. 10.1002/jev2.1207910.1002/jev2.12079 ↗
16. 10.3390/s15071764910.3390/s150717649 ↗
17. 10.1021/nn501312q10.1021/nn501312q ↗
18. 10.1038/srep3724610.1038/srep37246 ↗
19. 10.1016/j.aca.2020.03.00110.1016/j.aca.2020.03.001 ↗
20. 10.1002/anie.20160049510.1002/anie.201600495 ↗
21. 10.1002/cpns.7910.1002/cpns.79 ↗
22. 10.1126/science.280.5363.58510.1126/science.280.5363.585 ↗
23. 10.1038/gt.2017.810.1038/gt.2017.8 ↗
24. 10.3390/pharmaceutics1311193110.3390/pharmaceutics13111931 ↗
25. 10.1007/s11095-017-2123-510.1007/s11095-017-2123-5 ↗
26. 10.1126/sciadv.abc120410.1126/sciadv.abc1204 ↗
27. 10.1016/j.cell.2023.06.01310.1016/j.cell.2023.06.013 ↗
28. 10.1038/nrmicro274710.1038/nrmicro2747 ↗
29. 10.1006/viro.1997.849910.1006/viro.1997.8499 ↗
30. 10.3389/fmicb.2011.0024210.3389/fmicb.2011.00242 ↗
31. 10.1093/emboj/cdg14310.1093/emboj/cdg143 ↗
32. 10.1016/j.virol.2015.09.00610.1016/j.virol.2015.09.006 ↗
33. 10.1016/j.virol.2017.02.01610.1016/j.virol.2017.02.016 ↗
34. 10.1099/0022-1317-69-10-245510.1099/0022-1317-69-10-2455 ↗
35. 10.1371/journal.pone.003096310.1371/journal.pone.0030963 ↗
36. 10.1017/S146625231100001610.1017/S1466252311000016 ↗
37. 10.1186/1742-4690-6-2810.1186/1742-4690-6-28 ↗
38. 10.1002/jev2.1227110.1002/jev2.12271 ↗
39. 10.1038/s41598-017-01739-810.1038/s41598-017-01739-8 ↗
40. 10.2147/IJN.S13343010.2147/IJN.S133430 ↗
41. 10.1073/pnas.221633012010.1073/pnas.2216330120 ↗
42. 10.1093/nar/gkaa67410.1093/nar/gkaa674 ↗
43. 10.1093/nar/gkv43210.1093/nar/gkv432 ↗
44. 10.1016/S0079-6603(08)60842-910.1016/S0079-6603(08)60842-9 ↗
45. 10.1016/j.ijpharm.2021.12057110.1016/j.ijpharm.2021.120571 ↗
46. 10.1002/jmv.2872910.1002/jmv.28729 ↗
47. 10.1186/s12951-021-00806-710.1186/s12951-021-00806-7 ↗
48. 10.3390/ijms24161296310.3390/ijms241612963 ↗
49. 10.1073/pnas.152123011310.1073/pnas.1521230113 ↗
50. 10.2217/17435889.2.6.78910.2217/17435889.2.6.789 ↗
51. 10.3402/jev.v3.2691310.3402/jev.v3.26913 ↗
52. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
53. 10.1002/jev2.1218210.1002/jev2.12182 ↗
54. 10.1016/j.mcpro.2023.10055710.1016/j.mcpro.2023.100557 ↗
55. 10.1016/j.jconrel.2022.02.01710.1016/j.jconrel.2022.02.017 ↗
56. 10.1038/s41580-020-0251-y10.1038/s41580-020-0251-y ↗
57. 10.1002/jev2.1236910.1002/jev2.12369 ↗
58. 10.1371/journal.ppat.100223410.1371/journal.ppat.1002234 ↗
59. 10.1016/j.virol.2017.05.01710.1016/j.virol.2017.05.017 ↗
60. 10.1002/jev2.1211210.1002/jev2.12112 ↗
61. 10.1038/s41592-022-01460-z10.1038/s41592-022-01460-z ↗
62. 10.1093/nar/gkab23610.1093/nar/gkab236 ↗
63. 10.1186/s12985-023-01968-610.1186/s12985-023-01968-6 ↗
64. 10.1186/s12977-018-0424-310.1186/s12977-018-0424-3 ↗
65. 10.1128/JVI.77.22.11896-11909.200310.1128/JVI.77.22.11896-11909.2003 ↗
66. 10.1002/advs.20230055210.1002/advs.202300552 ↗
67. 10.1007/978-1-61779-005-8_110.1007/978-1-61779-005-8_1 ↗